Articles Posted in Patent Infringement

Indianapolis, Indiana – Patent lawyers for Eli Lilly and Company of Indianapolis, IN, have initiated litigation alleging Hospira, Inc. of Lake Forest, IL of Lake Forest, IL, has infringed and will infringe the following two patents, as issued by the U.S. Patent Office: Patent No. 4,808,614, titled DIFLUORO ANTIVIRALS AND INTERMEDIATE THEREFOR, and Patent No. 5,464,826, titled METHOD OF TREATING TUMORS IN MAMMALS WITH 2′,2′-DIFLUORONUCLEOSIDES.

The ‘826 patent covers the drug marketed under the name GEMZAR(R) for the treatment of abnormal masses of tissue known as neoplasms. The complaint notes that, in a separate lawsuit, the ‘826 patent was found invalid on grounds of obviousness-type double patenting, but that Lilly has appealed to the Federal Circuit and believes the ruling will be reversed. Lilly also holds approved New Drug Application No. 20-509 for the use of GEMZAR(R) as a treatment for certain types of cancer.
Continue reading

Indianapolis, Indiana – Patent lawyers for One Number Corporation of Anderson, IN, have filed a lawsuit alleging Google, Inc. of Mountain View, CA, has infringed the following two patents, as issued by the U.S. Patent Office: Patent No. 7,440,565, titled CONTACT NUMBER ENCAPSULATION SYSTEM, and Patent No. 7,680,256, titled CONTACT NUMBER ENCAPSULATION SYSTEM.

The asserted patents claim telecommunications systems which allow a user to obtain a telephone number that is associated with the individual, rather than being tied to a specific location or phone. The plaintiff’s complaint alleges that the defendant’s Google Voice PC-to-phone service, as well as the GrandCentral technology which defendant previously acquired, infringes both patents.
Continue reading

 Indianapolis, Indiana – Patent attorneys for Eli Lilly and Company of Indianapolis, IN, and its subsidiary ICOS Corporation of Indianapolis, IN, initiated litigation alleging Synthon Pharmaceuticals, Inc. of Research Triangle Park, NC, have infringed the following two patents, as issued by the US Patent Office: Patent No. 6,821,975, titled BETA-CARBOLINE DRUG PRODUCTS, and Patent No. 7,182,958, titled BETA.-CARBOLINE PHARMACEUTICAL COMPOSITIONS.
Continue reading

 Indianapolis, Indiana – Patent lawyers for Alcon Research, Ltd and Alcon Laboratories, Inc., both of Fort Worth, TX, filed a lawsuit alleging Wockhardt Limited of Maharashta, India, and Wockhardt USA, LLC, of Parsippany, NJ, have infringed, and will infringe, Patent No. 5,641,805, titled TOPICAL OPTHTHALMIC FORMULATIONS FOR TREATING ALLERGIC EYE DISEASES, as issued by the U.S. Patent Office.
Continue reading

Indianapolis, Indiana – Patent attorneys for GS Cleantech Corporation of New York, NY, filed an infringement suit alleging Cardinal Ethanol, LLC of Union City, IN, has infringed Patent No. 7,601,858, titled METHOD OF PROCESSING ETHANOL BYPRODUCTS AND RELATED SUBSYSTEMS, as issued by the U.S. Patent Office.

The ‘858 patent is directed to the recovery of corn oil from the byproducts produced during ethanol manufacture, and the defendant is generally alleged to be practicing one or more of the claimed methods.
Continue reading

 Indianapolis, Indiana – Patent lawyers for Eli Lilly and Company of Indianapolis, IN, have initiated litigation alleging Fresenius Kabi Oncology PLC of London, United Kingdom, has infringed and will infringe the following two patents, as issued by the U.S. Patent Office: Patent No. 4,808,614, titled DIFLUORO ANTIVIRALS AND INTERMEDIATE THEREFOR, and Patent No. 5,464,826, titled METHOD OF TREATING TUMORS IN MAMMALS WITH 2′,2′-DIFLUORONUCLEOSIDES.
Continue reading

 Indianapolis, Indiana – Patent lawyers for Alcon Research, Ltd. and Alcon Laboratories, Inc., both of Fort Worth, TX, Alcon Pharmaceuticals, Ltd. of Fribourg, Switzerland, and Kyowa Hakko Kirin Co., Ltd. of Tokyo, Japan, filed a patent infringement suit alleging Sandoz Inc. of Princeton, NJ, has infringed, and will infringe, the following three patents, as issued by the U.S. Patent Office: Patent No. 5,641,805, titled TOPICAL OPHTHALMIC FORMULATIONS FOR TREATING ALLERGIC EYE DISEASES; Patent No. 6,995,186, titled OLOPATADINE FORMULATIONS FOR TOPICAL ADMINISTRATION; and Patent No. 7,402,609, titled OLOPATADINE FORMULATIONS FOR TOPICAL ADMINISTRATION.
Continue reading

Indianapolis, Indiana – Patent lawyers for Sepro Corporation of Carmel, IN, filed an infringement suit alleging Phoenix Environmental Care, LLC of Valdosta, GA, infringed Patent No. 7,135,435, titled PLANT GROWTH REGULATION COMPOSITIONS AND METHODS USING GIBBERELLIN BIOSYNTHESIS INHIBITOR COMBINATIONS, as issued by the U.S. Patent Office.

The plaintiff makes and sells aquatic and horticultural products, and its ‘435 patent relates to plant growth regulation compositions, while the defendant is a chemical company in the business of marketing fungicides, herbicides, and insecticides. The complaint claims that the defendant has directly infringed the ‘435 patent by marketing an infringing turf growth regulation composition and induced infringement of the patent by directing a university study of the composition.
Continue reading